Cyanate	B:C0302938
-	O
Impaired	O
Angiogenesis	O
:	O
Association	O
With	O
Poor	O
Coronary	O
Collateral	I:C1820269
Growth	I:C1820269
in	O
Patients	O
With	O
Stable	O
Angina	I:C0340288
and	O
Chronic	O
Total	I:C1955779
Occlusion	I:C1955779
Cyanate	O
has	O
recently	O
gained	O
attention	O
for	O
its	O
role	O
in	O
the	O
pathogenesis	O
of	O
vascular	O
injury	I:C0178324
.	O

Cyanate	O
-	O
Impaired	O
Angiogenesis	B:C0302600
:	O
Association	O
With	O
Poor	O
Coronary	O
Collateral	I:C1820269
Growth	I:C1820269
in	O
Patients	O
With	O
Stable	O
Angina	I:C0340288
and	O
Chronic	O
Total	I:C1955779
Occlusion	I:C1955779
Cyanate	O
has	O
recently	O
gained	O
attention	O
for	O
its	O
role	O
in	O
the	O
pathogenesis	O
of	O
vascular	O
injury	I:C0178324
.	O

Cyanate	O
-	O
Impaired	O
Angiogenesis	O
:	O
Association	O
With	O
Poor	O
Coronary	B:C1820269
Collateral	I:C1820269
Growth	I:C1820269
in	O
Patients	O
With	O
Stable	O
Angina	I:C0340288
and	O
Chronic	O
Total	I:C1955779
Occlusion	I:C1955779
Cyanate	O
has	O
recently	O
gained	O
attention	O
for	O
its	O
role	O
in	O
the	O
pathogenesis	O
of	O
vascular	O
injury	I:C0178324
.	O

Cyanate	O
-	O
Impaired	O
Angiogenesis	O
:	O
Association	O
With	O
Poor	O
Coronary	O
Collateral	I:C1820269
Growth	I:C1820269
in	O
Patients	O
With	O
Stable	B:C0340288
Angina	I:C0340288
and	O
Chronic	O
Total	I:C1955779
Occlusion	I:C1955779
Cyanate	O
has	O
recently	O
gained	O
attention	O
for	O
its	O
role	O
in	O
the	O
pathogenesis	O
of	O
vascular	O
injury	I:C0178324
.	O

Cyanate	O
-	O
Impaired	O
Angiogenesis	O
:	O
Association	O
With	O
Poor	O
Coronary	O
Collateral	I:C1820269
Growth	I:C1820269
in	O
Patients	O
With	O
Stable	O
Angina	I:C0340288
and	O
Chronic	B:C1955779
Total	I:C1955779
Occlusion	I:C1955779
Cyanate	O
has	O
recently	O
gained	O
attention	O
for	O
its	O
role	O
in	O
the	O
pathogenesis	O
of	O
vascular	O
injury	I:C0178324
.	O

Cyanate	O
-	O
Impaired	O
Angiogenesis	O
:	O
Association	O
With	O
Poor	O
Coronary	O
Collateral	I:C1820269
Growth	I:C1820269
in	O
Patients	O
With	O
Stable	O
Angina	I:C0340288
and	O
Chronic	O
Total	I:C1955779
Occlusion	I:C1955779
Cyanate	B:C0302938
has	O
recently	O
gained	O
attention	O
for	O
its	O
role	O
in	O
the	O
pathogenesis	O
of	O
vascular	O
injury	I:C0178324
.	O

Cyanate	O
-	O
Impaired	O
Angiogenesis	O
:	O
Association	O
With	O
Poor	O
Coronary	O
Collateral	I:C1820269
Growth	I:C1820269
in	O
Patients	O
With	O
Stable	O
Angina	I:C0340288
and	O
Chronic	O
Total	I:C1955779
Occlusion	I:C1955779
Cyanate	O
has	O
recently	O
gained	O
attention	O
for	O
its	O
role	O
in	O
the	O
pathogenesis	B:C0699748
of	O
vascular	O
injury	I:C0178324
.	O

Cyanate	O
-	O
Impaired	O
Angiogenesis	O
:	O
Association	O
With	O
Poor	O
Coronary	O
Collateral	I:C1820269
Growth	I:C1820269
in	O
Patients	O
With	O
Stable	O
Angina	I:C0340288
and	O
Chronic	O
Total	I:C1955779
Occlusion	I:C1955779
Cyanate	O
has	O
recently	O
gained	O
attention	O
for	O
its	O
role	O
in	O
the	O
pathogenesis	O
of	O
vascular	B:C0178324
injury	I:C0178324
.	O

Nonetheless	O
,	O
the	O
effect	O
of	O
cyanate	B:C0302938
on	O
angiogenesis	O
remains	O
unclear	O
.	O

Nonetheless	O
,	O
the	O
effect	O
of	O
cyanate	O
on	O
angiogenesis	B:C0302600
remains	O
unclear	O
.	O

In	O
this	O
study	B:C2603343
,	O
we	O
demonstrated	O
that	O
oral	O
administration	I:C0001563
of	O
cyanate	O
impaired	O
blood	O
perfusion	O
recovery	O
in	O
a	O
mouse	O
hind	I:C2986594
-	I:C2986594
limb	I:C2986594
ischemia	I:C2986594
model	I:C2986594
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
oral	B:C0001563
administration	I:C0001563
of	O
cyanate	O
impaired	O
blood	O
perfusion	O
recovery	O
in	O
a	O
mouse	O
hind	I:C2986594
-	I:C2986594
limb	I:C2986594
ischemia	I:C2986594
model	I:C2986594
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
oral	O
administration	I:C0001563
of	O
cyanate	B:C0302938
impaired	O
blood	O
perfusion	O
recovery	O
in	O
a	O
mouse	O
hind	I:C2986594
-	I:C2986594
limb	I:C2986594
ischemia	I:C2986594
model	I:C2986594
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
oral	O
administration	I:C0001563
of	O
cyanate	O
impaired	O
blood	O
perfusion	O
recovery	O
in	O
a	O
mouse	B:C2986594
hind	I:C2986594
-	I:C2986594
limb	I:C2986594
ischemia	I:C2986594
model	I:C2986594
.	O

A	O
reduction	B:C0441610
in	O
blood	O
perfusion	O
recovery	O
at	O
day	O
21	O
was	O
observed	O
in	O
the	O
ischemic	O
tissue	O
of	O
cyanate	O
-	O
treated	O
mice	O
.	O

A	O
reduction	O
in	O
blood	O
perfusion	O
recovery	O
at	O
day	O
21	O
was	O
observed	O
in	O
the	O
ischemic	O
tissue	B:C0040300
of	O
cyanate	O
-	O
treated	O
mice	O
.	O

A	O
reduction	O
in	O
blood	O
perfusion	O
recovery	O
at	O
day	O
21	O
was	O
observed	O
in	O
the	O
ischemic	O
tissue	O
of	O
cyanate	B:C0302938
-	O
treated	O
mice	O
.	O

A	O
reduction	O
in	O
blood	O
perfusion	O
recovery	O
at	O
day	O
21	O
was	O
observed	O
in	O
the	O
ischemic	O
tissue	O
of	O
cyanate	O
-	O
treated	O
mice	B:C0025929
.	O

Likewise	O
,	O
there	O
were	O
fewer	O
capillaries	B:C0006901
in	O
the	O
ischemic	O
hind	O
-	I:C1522391
limb	I:C1522391
tissue	O
of	O
cyanate	O
-	O
exposed	O
mice	O
.	O

Likewise	O
,	O
there	O
were	O
fewer	O
capillaries	O
in	O
the	O
ischemic	O
hind	B:C1522391
-	I:C1522391
limb	I:C1522391
tissue	O
of	O
cyanate	O
-	O
exposed	O
mice	O
.	O

Likewise	O
,	O
there	O
were	O
fewer	O
capillaries	O
in	O
the	O
ischemic	O
hind	O
-	I:C1522391
limb	I:C1522391
tissue	B:C0040300
of	O
cyanate	O
-	O
exposed	O
mice	O
.	O

Likewise	O
,	O
there	O
were	O
fewer	O
capillaries	O
in	O
the	O
ischemic	O
hind	O
-	I:C1522391
limb	I:C1522391
tissue	O
of	O
cyanate	B:C0302938
-	O
exposed	O
mice	O
.	O

Likewise	O
,	O
there	O
were	O
fewer	O
capillaries	O
in	O
the	O
ischemic	O
hind	O
-	I:C1522391
limb	I:C1522391
tissue	O
of	O
cyanate	O
-	O
exposed	O
mice	B:C0025929
.	O

Our	O
in	O
vitro	O
study	B:C2603343
showed	O
that	O
cyanate	O
,	O
together	O
with	O
its	O
carbamylated	O
products	O
,	O
inhibited	O
the	O
migration	O
,	O
proliferation	O
,	O
and	O
tube	O
-	I:C2752214
formation	I:C2752214
abilities	O
of	O
endothelial	O
cells	I:C0225336
.	O

Our	O
in	O
vitro	O
study	O
showed	O
that	O
cyanate	B:C0302938
,	O
together	O
with	O
its	O
carbamylated	O
products	O
,	O
inhibited	O
the	O
migration	O
,	O
proliferation	O
,	O
and	O
tube	O
-	I:C2752214
formation	I:C2752214
abilities	O
of	O
endothelial	O
cells	I:C0225336
.	O

Our	O
in	O
vitro	O
study	O
showed	O
that	O
cyanate	O
,	O
together	O
with	O
its	O
carbamylated	O
products	O
,	O
inhibited	O
the	O
migration	B:C1622501
,	O
proliferation	O
,	O
and	O
tube	O
-	I:C2752214
formation	I:C2752214
abilities	O
of	O
endothelial	O
cells	I:C0225336
.	O

Our	O
in	O
vitro	O
study	O
showed	O
that	O
cyanate	O
,	O
together	O
with	O
its	O
carbamylated	O
products	O
,	O
inhibited	O
the	O
migration	O
,	O
proliferation	B:C0596290
,	O
and	O
tube	O
-	I:C2752214
formation	I:C2752214
abilities	O
of	O
endothelial	O
cells	I:C0225336
.	O

Our	O
in	O
vitro	O
study	O
showed	O
that	O
cyanate	O
,	O
together	O
with	O
its	O
carbamylated	O
products	O
,	O
inhibited	O
the	O
migration	O
,	O
proliferation	O
,	O
and	O
tube	B:C2752214
-	I:C2752214
formation	I:C2752214
abilities	O
of	O
endothelial	O
cells	I:C0225336
.	O

Our	O
in	O
vitro	O
study	O
showed	O
that	O
cyanate	O
,	O
together	O
with	O
its	O
carbamylated	O
products	O
,	O
inhibited	O
the	O
migration	O
,	O
proliferation	O
,	O
and	O
tube	O
-	I:C2752214
formation	I:C2752214
abilities	O
of	O
endothelial	B:C0225336
cells	I:C0225336
.	O

Further	O
research	B:C0035168
revealed	O
that	O
cyanate	O
regulated	O
angiogenesis	O
partly	O
by	O
interrupting	O
the	O
vascular	O
endothelial	I:C0378796
growth	I:C0378796
factor	I:C0378796
receptor	I:C0378796
2	I:C0378796
/	O
phosphatidylinositol	O
3	I:C0044602
-	I:C0044602
kinase	I:C0044602
/	O

Further	O
research	O
revealed	O
that	O
cyanate	B:C0302938
regulated	O
angiogenesis	O
partly	O
by	O
interrupting	O
the	O
vascular	O
endothelial	I:C0378796
growth	I:C0378796
factor	I:C0378796
receptor	I:C0378796
2	I:C0378796
/	O
phosphatidylinositol	O
3	I:C0044602
-	I:C0044602
kinase	I:C0044602
/	O

Further	O
research	O
revealed	O
that	O
cyanate	O
regulated	O
angiogenesis	B:C0302600
partly	O
by	O
interrupting	O
the	O
vascular	O
endothelial	I:C0378796
growth	I:C0378796
factor	I:C0378796
receptor	I:C0378796
2	I:C0378796
/	O
phosphatidylinositol	O
3	I:C0044602
-	I:C0044602
kinase	I:C0044602
/	O

Further	O
research	O
revealed	O
that	O
cyanate	O
regulated	O
angiogenesis	O
partly	O
by	O
interrupting	O
the	O
vascular	B:C0378796
endothelial	I:C0378796
growth	I:C0378796
factor	I:C0378796
receptor	I:C0378796
2	I:C0378796
/	O
phosphatidylinositol	O
3	I:C0044602
-	I:C0044602
kinase	I:C0044602
/	O

Further	O
research	O
revealed	O
that	O
cyanate	O
regulated	O
angiogenesis	O
partly	O
by	O
interrupting	O
the	O
vascular	O
endothelial	I:C0378796
growth	I:C0378796
factor	I:C0378796
receptor	I:C0378796
2	I:C0378796
/	O
phosphatidylinositol	B:C0044602
3	I:C0044602
-	I:C0044602
kinase	I:C0044602
/	O

Akt	B:C1515844
pathway	I:C1515844
.	O

The	O
serum	O
concentrations	O
of	O
homocitrulline	B:C0062931
,	O
a	O
marker	O
of	O
cyanate	O
exposure	O
,	O
were	O
determined	O
in	O
117	O
patients	O
with	O
stable	O
angina	I:C0340288
and	O
chronic	O
total	I:C1955779
occlusion	I:C1955779
.	O

The	O
serum	O
concentrations	O
of	O
homocitrulline	O
,	O
a	O
marker	B:C0005516
of	O
cyanate	O
exposure	O
,	O
were	O
determined	O
in	O
117	O
patients	O
with	O
stable	O
angina	I:C0340288
and	O
chronic	O
total	I:C1955779
occlusion	I:C1955779
.	O

The	O
serum	O
concentrations	O
of	O
homocitrulline	O
,	O
a	O
marker	O
of	O
cyanate	B:C0302938
exposure	O
,	O
were	O
determined	O
in	O
117	O
patients	O
with	O
stable	O
angina	I:C0340288
and	O
chronic	O
total	I:C1955779
occlusion	I:C1955779
.	O

The	O
serum	O
concentrations	O
of	O
homocitrulline	O
,	O
a	O
marker	O
of	O
cyanate	O
exposure	O
,	O
were	O
determined	O
in	O
117	O
patients	O
with	O
stable	B:C0340288
angina	I:C0340288
and	O
chronic	O
total	I:C1955779
occlusion	I:C1955779
.	O

The	O
serum	O
concentrations	O
of	O
homocitrulline	O
,	O
a	O
marker	O
of	O
cyanate	O
exposure	O
,	O
were	O
determined	O
in	O
117	O
patients	O
with	O
stable	O
angina	I:C0340288
and	O
chronic	B:C1955779
total	I:C1955779
occlusion	I:C1955779
.	O

Consistent	O
with	O
the	O
antiangiogenic	B:C3179230
role	I:C3179230
of	O
cyanate	O
,	O
homocitrulline	O
levels	I:C0523699
were	O
increased	O
in	O
patients	O
with	O
poor	O
coronary	O
collateralization	I:C1820269
(	O
n=58	O
)	O
compared	O
with	O
those	O
with	O
high	O
collateralization	O
(	O
n=59	O
;	O
21.09±13.08	O
versus	O
15.54±9.02	O
ng/mL	O
,	O
P=0.009	O
)	O
.	O

Consistent	O
with	O
the	O
antiangiogenic	O
role	I:C3179230
of	O
cyanate	B:C0302938
,	O
homocitrulline	O
levels	I:C0523699
were	O
increased	O
in	O
patients	O
with	O
poor	O
coronary	O
collateralization	I:C1820269
(	O
n=58	O
)	O
compared	O
with	O
those	O
with	O
high	O
collateralization	O
(	O
n=59	O
;	O
21.09±13.08	O
versus	O
15.54±9.02	O
ng/mL	O
,	O
P=0.009	O
)	O
.	O

Consistent	O
with	O
the	O
antiangiogenic	O
role	I:C3179230
of	O
cyanate	O
,	O
homocitrulline	B:C0523699
levels	I:C0523699
were	O
increased	O
in	O
patients	O
with	O
poor	O
coronary	O
collateralization	I:C1820269
(	O
n=58	O
)	O
compared	O
with	O
those	O
with	O
high	O
collateralization	O
(	O
n=59	O
;	O
21.09±13.08	O
versus	O
15.54±9.02	O
ng/mL	O
,	O
P=0.009	O
)	O
.	O

Consistent	O
with	O
the	O
antiangiogenic	O
role	I:C3179230
of	O
cyanate	O
,	O
homocitrulline	O
levels	I:C0523699
were	O
increased	O
in	O
patients	O
with	O
poor	O
coronary	B:C1820269
collateralization	I:C1820269
(	O
n=58	O
)	O
compared	O
with	O
those	O
with	O
high	O
collateralization	O
(	O
n=59	O
;	O
21.09±13.08	O
versus	O
15.54±9.02	O
ng/mL	O
,	O
P=0.009	O
)	O
.	O

Consistent	O
with	O
the	O
antiangiogenic	O
role	I:C3179230
of	O
cyanate	O
,	O
homocitrulline	O
levels	I:C0523699
were	O
increased	O
in	O
patients	O
with	O
poor	O
coronary	O
collateralization	I:C1820269
(	O
n=58	O
)	O
compared	O
with	O
those	O
with	O
high	O
collateralization	B:C1948058
(	O
n=59	O
;	O
21.09±13.08	O
versus	O
15.54±9.02	O
ng/mL	O
,	O
P=0.009	O
)	O
.	O

In	O
addition	O
,	O
elevated	O
homocitrulline	B:C0062931
concentration	O
was	O
a	O
strong	O
predictor	O
of	O
poor	O
coronary	O
collateral	I:C1820269
growth	I:C1820269
.	O

In	O
addition	O
,	O
elevated	O
homocitrulline	O
concentration	O
was	O
a	O
strong	O
predictor	O
of	O
poor	O
coronary	B:C1820269
collateral	I:C1820269
growth	I:C1820269
.	O

Impaired	O
angiogenesis	B:C0302600
induced	O
by	O
cyanate	O
might	O
contribute	O
to	O
poor	O
coronary	O
collateral	I:C1820269
growth	I:C1820269
.	O

Impaired	O
angiogenesis	O
induced	O
by	O
cyanate	B:C0302938
might	O
contribute	O
to	O
poor	O
coronary	O
collateral	I:C1820269
growth	I:C1820269
.	O

Impaired	O
angiogenesis	O
induced	O
by	O
cyanate	O
might	O
contribute	O
to	O
poor	O
coronary	B:C1820269
collateral	I:C1820269
growth	I:C1820269
.	O

